Press Resease

Home infusion therapy Market - Global Industry Analysis

Home infusion therapy Market By Product (Infusion Pump, Intravenous Sets, IV Cannulas, and Needleless Connectors), By Application Type (Anti-Infectives, Endocrinology, Enteral nutrition, Hydration Therapy, and Parenteral Nutrition): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 27-Jul-2021 Category: Healthcare Report Format : PDF Pages: 145 Report Code: ZMR-2278 Status : Published

The global Home infusion therapy market accounted for USD 23.0 Billion in 2020 and is expected to reach USD 55.5 Billion by 2028, growing at a CAGR of around 11.2% between 2021 and 2028.

Description

Market Overview     

The global Home infusion therapy market accounted for USD 23.0 Billion in 2020 and is expected to reach USD 55.5 Billion by 2028, growing at a CAGR of around 11.2% between 2021 and 2028.      

Infusion therapy involves the administration of drug intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Technological advances have enabled safe and effective administration of infusion therapies at home. Infusion therapy is required in several health conditions which include infections that are not responsive to oral antibiotics, cancer-related pain, dehydration, gastrointestinal disorders and much more. For individuals requiring long-term therapy, inpatient care is needed Home infusion has been proven to be a safe and effective alternative.

COVID-19 Impact Analysis  

The global Home infusion therapy market has witnessed a significant growth in the sales during the COVID-19 pandemic. This is due to considerable growth in adoption rate of home infusion therapies.

Growing number of the market players are investing more on research and development in the field which is predicted to create growth opportunities in the estimated period. For instance, In April 2020, B. Braun infusion pumps receive FDA emergency use authorization with nebulizers to treat COVID-19 patients for all ages. In addition, advancement of technology is expected to create lucrative growth opportunity for the market in the forecast period. For instance in July 2020, Biocon biologics and Voluntis joined hands for global collaboration on digital therapeutics for insulins which develops as well as distributes innovative digital therapeutics supporting people with diabetes on biologics therapy. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Growth Factors

Global home infusion therapy market is primarily driven by growing aging population and prevalence of chronic diseases such as cancer, obesity, diabetes, asthma, and other life-threatening conditions. In addition to this, the adoption of home infusion therapy products as well as services in underdeveloped and developed regions has augmented due to cost-effective treatments in the past few years, thereby fueling growth of the market

Nonetheless, rising preference for homecare facilities is likely to disclose the new avenues for home infusion therapy market in the near future.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

Based on Product type, the market can be segmented into the infusion pump, intravenous sets, IV cannulas and needleless connectors.  Infusion pump was the major segment and it accounted the major share of total revenue generated in 2020. Needleless connectors are fastest growing segments in this market. On the basis of application type, the market is divided into anti-infectives, endocrinology, enteral nutrition, hydration therapy, chemotherapy, parenteral infusion, immunoglobulin infusion and others. Anti-infectives was the major segment and it accounted for over maximum share of total revenue generated in 2020. Enteral nutrition, parenteral infusion, and chemotherapy were the fastest growing segments in this market.

Regional Analysis Preview  

The global home infusion therapy market by North America and it held a maximum share of total revenue generated in 2020. This growth can be attributed to the presence of key players and good health awareness among people. The growth is also due to a large number of chronic diseases and growing geriatric population in this region. There is a significant increase in IV based therapy drugs to treat chronic and rare diseases (including blood factors, corticosteroids, growth hormones, immunoglobulin, monoclonal therapies and others) are being infused in home settings. There is a rise in adoption of home infusion therapy in the administration of anti-infectives such as antibiotics, antiviral, antifungal drugs, chemotherapy drugs, parenteral nutrition, hydration products and pain management.

Europe is another leading regional market followed by North America on account of advanced medical facilities and growing number of specialty-pharmacy and home-infusion centers in European countries. The region has a lot to offer, as the population is more health conscious and faster adoption rate of home infusion therapy due to rise in per capita income. Asia Pacific was a fastest growing market on account of rising geriatric population, rising disposable income and increasing consumer spending towards healthcare. The region is fastest developing owing to raising awareness among people regarding the use of infusion drug therapies in hospitals and healthcare facilities. Latin America was emerging market with rising healthcare infrastructure. Brazil and rest of Latin America are anticipated to fuel the market growth in coming years.

Key Market Players & Competitive Landscape

Some of the major players of the global home infusion therapy market include Baxter, B. Braun Melsungen AG, Care Fusion Corporation, ICU Medical, Inc., Fresenius Kabi AG, JMS Co. Ltd., Terumo Corporation, Smiths Medical and Caesarea Medical Electronics among others.

The global Home Infusion Therapy Market is segmented as follows:

By Products

  • Infusion Pump
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

By Application Types

  • Anti-Infectives
  • Endocrinology
  • Enteral nutrition
  • Hydration Therapy
  • Parenteral Nutrition

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By Application Type
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Home infusion therapy Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Home infusion therapy Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Infusion Pump
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Intravenous Sets
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. IV Cannulas
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Needleless Connectors
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Home infusion therapy Market – Application Type Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application Type, 2020 & 2028
    • 5.2. Anti-Infectives
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Endocrinulogy
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Enteral nutrition
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Hydration Therapy
      • 5.5.1. Market Size and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Parenteral Nutrition
      • 5.6.1. Market Size and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application Type, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application Type, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application Type, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application Type, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application Type, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application Type, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application Type, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application Type, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application Type, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application Type, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application Type, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application Type, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application Type, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application Type, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application Type, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application Type, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application Type, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application Type, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application Type, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application Type, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application Type, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application Type, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application Type, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application Type, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application Type, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application Type, 2016 – 2028
  • Chapter No. 7: Home infusion therapy Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Home infusion therapy Market: Company Market Share, 2019
      • 8.1.2. Global Home infusion therapy Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Home infusion therapy Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Home infusion therapy Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Baxter
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. B. Braun Melsungen AG
    • 9.3. Care Fusion Corporation
    • 9.4. ICU Medical, Inc.
    • 9.5. Fresenius Kabi AG
    • 9.6. JMS Co. Ltd.
    • 9.7. Terumo Corporation
    • 9.8. Smiths Medical
    • 9.9. Caesarea Medical Electronics
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By Application Type
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Home infusion therapy Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 7. Global Home infusion therapy Market for Infusion Pump, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Home infusion therapy Market for Infusion Pump, By Country, 2020 & 2028
FIG NO. 9. Global Home infusion therapy Market for Intravenous Sets, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Home infusion therapy Market for Intravenous Sets, By Country, 2020 & 2028
FIG NO. 11. Global Home infusion therapy Market for IV Cannulas, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Home infusion therapy Market for IV Cannulas, By Country, 2020 & 2028
FIG NO. 13. Global Home infusion therapy Market for Needleless Connectors, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Home infusion therapy Market for Needleless Connectors, By Country, 2020 & 2028
FIG NO. 15. Global Home infusion therapy Market for Brachytherapy Seeds, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Market Revenue Share, By Application Type, 2020 & 2028
FIG NO. 17. Global Home infusion therapy Market for Anti-Infectives, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Home infusion therapy Market for Anti-Infectives, By Country, 2020 & 2028 
FIG NO. 19. Global Home infusion therapy Market for Endocrinology, Revenue (USD Billion) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Home infusion therapy Market for Endocrinology, By Country, 2020 & 2028
FIG NO. 21. Global Home infusion therapy Market for Enteral nutrition, Revenue (USD Billion) 2016 – 2028 
FIG NO. 22. Comparative Revenue Analysis of Home infusion therapy Market for Enteral nutrition, By Country, 2020 & 2028
FIG NO. 23. Global Home infusion therapy Market for Hydration Therapy, Revenue (USD Billion) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Home infusion therapy Market for Hydration Therapy, By Country, 2020 & 2028
FIG NO. 25. Global Home infusion therapy Market for Parenteral Nutrition, Revenue (USD Billion) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Home infusion therapy Market for Parenteral Nutrition, By Country, 2020 & 2028
FIG NO. 27. Global Home infusion therapy Market Revenue Share, By Region, 2020 & 2028
FIG NO. 28. North America Home infusion therapy Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 29. Porter’s Five Forces Analysis for Global Home infusion therapy Market
FIG NO. 30. PEST Analysis for Global Home infusion therapy Market
FIG NO. 31. Pricing Analysis for Global Home infusion therapy Market
FIG NO. 32. Value Chain Analysis for Global Home infusion therapy Market
FIG NO. 33. Company Share Analysis, 2019
FIG NO. 34. Radar Determinant Chart, 2019
FIG NO. 35. Company Strategic Developments – Heat Map Analysis
FIG NO. 36. Baxter Business Segment Revenue Share, 2020 (%)
FIG NO. 37. Baxter Geographical Segment Revenue Share, 2020 (%)
FIG NO. 38. Market Channels
FIG NO. 39. Marketing Channel Development Trend
FIG NO. 40. Growth in World Gross Product, 2008-2018
FIG NO. 41. Research Methodology – Detailed View
FIG NO. 42. Research Methodology


List of Tables 

TABLE NO. 1. Global Home infusion therapy Market: Snapshot
TABLE NO. 2. Quarterly Home infusion therapy Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Home infusion therapy Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Home infusion therapy Market for Infusion Pump, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Home infusion therapy Market for Intravenous Sets, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Home infusion therapy Market for IV Cannulas, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Home infusion therapy Market for Needleless Connectors, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Home infusion therapy Market for Anti-Infectives, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11 Global Home infusion therapy Market for Endocrinology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Home infusion therapy Market for Enteral nutrition, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Home infusion therapy Market for Hydration Therapy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Home infusion therapy Market for Parenteral Nutrition, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Home infusion therapy Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. North America Home infusion therapy Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 17. North America Home infusion therapy Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 18. North America Home infusion therapy Market Revenue, By Application Type, 2016 – 2028 (USD Billion)
TABLE NO. 19. U.S. Home infusion therapy Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 20. U.S. Home infusion therapy Market Revenue, By Application Type, 2016 – 2028 (USD Billion)
TABLE NO. 21. Canada Home infusion therapy Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 22. Canada Home infusion therapy Market Revenue, By Application Type, 2016 – 2028 (USD Billion)
TABLE NO. 23. Mexico Home infusion therapy Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 24. Mexico Home infusion therapy Market Revenue, By Application Type, 2016 – 2028 (USD Billion)
TABLE NO. 25. Drivers for the Home infusion therapy Market: Impact Analysis
TABLE NO. 26. Restraints for the Home infusion therapy Market: Impact Analysis
TABLE NO. 27. Major Buyers of Home infusion therapy  
TABLE NO. 28. Distributors/Traders List of Home infusion therapy
TABLE NO. 29. Global Home infusion therapy Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 30: Global Home infusion therapy Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Home Infusion Therapy market. Zion Research has collected and analyzed key data belong to the global Home Infusion Therapy market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Home Infusion Therapy across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Home Infusion Therapy industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Home Infusion Therapy market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Infusion therapy is medication which is delivered through a needle or catheter via the intravenous or subcutaneous application. Infusion therapy offers immediate therapeutic effect. Nowadays, there is an increase in trend of infusion therapy at home through specialty-pharmacy, clinics, and home-infusion companies. It replaces the need for regular travel to the clinic of a doctor to who administers infusion therapy, or to a clinic that specializes in IV treatments. Home infusion care provides medications and a trained staff that is able to treat patients at the place of residence. Receiving therapy at home, outside the hospital or clinic setting, can be a good option for people those are facing a chronic illness, getting better from surgery, or being treated for an infection. Home infusion therapy offers cost-effective, safe alternative to an extended hospital stay. 

The home infusion therapy market is expected to witness a robust growth in the near future. The market is mainly driven by growing geriatric population and increasing prevalence of chronic diseases. In addition, rising geriatric population, increase in disease burden, and presence of high unmet medical needs in the low-income regions is resulting into increased demand for home infusion therapy market. Furthermore, Home infusion imparts significant cost savings as compared to the traditional infusion hospital settings which majorly account to the growth of the market. Moreover, growing awareness regarding noninvasive devices along with wide adoption of healthcare devices by population are expected to drive the growth of the market. However, the risk associated with the dose administration, lack of quality workforce, improper use of infusion devices and fewer reimbursement policies in underdeveloped countries are restraining the growth of the market. Technological advancements in medical devices and robust pipeline of infusible drugs are expected to present rewarding opportunities in the market in near future.

Global-Home-Infusion-Therapy-Market

The home infusion therapy market is classified based on product type, application type, and region. On the basis of product type market is divided into the infusion pump, intravenous sets, IV cannulas and needleless connectors. The needleless connectors segment is expected to witness the highest growth over forecast period owing to its noninvasive nature reducing needle stick injuries. The home infusion therapy is led by infusion pump and intravenous sets which account the maximum share in the market due to its rising use in intravenous therapy procedures all around the world. The popularity of Needleless connectors is spreading rapidly owing to its noninvasive nature and prevention of needle stick injuries. On the basis of application type, the market is divided into anti-infectives, enteral nutrition, hydration therapy, chemotherapy, parenteral nutrition, endocrinology and other. Anti-infectives segment which includes antibiotics and antifungal infusion treatment accounted maximum share out of the total revenue generated. Enteral and IVIg were the other segments which followed Anti-infectives segment.

Globally, demand for infusion therapy is on the rise, with North America and Europe leading the way. By geography, North America dominates the home infusion therapy owing presence of home infusion therapy providers and favorable reimbursement policies. In addition growing healthcare expenditure and increasing incidences of chronic diseases such as cancer, diabetes, immune deficiencies as a result of unhealthy lifestyle and lengthening the lifespan of the senior population and are accounting the growth in this region. Europe was the second after North America in terms of revenue generation. Preference for lower cost, high-quality outpatient treatment, and growing health-conscious population are the factors driving the growth in this region.

Asia Pacific was a fastest growing market. India and China are the major shareholders in this region. The growth is generally due to increasing aging population and rising chronic diseases. In addition rising disposable income, growing number of home infusion therapy providers are impacting growth in this region. Furthermore, raising awareness and emergence of the health-conscious population is expected to foster growth in future. Latin America is another key regional market and is expected to moderate growth in the coming years owing to rising healthcare infrastructure and raising awareness among the people. The Middle East and Africa are anticipated to witness significant growth within the forecast period.


Frequently Asked Questions

The global Home infusion therapy Market was valued at USD 23.0 billion in 2020.

The global Home infusion therapy Market is expected to reach USD 55.5 billion by 2028, growing at a CAGR of 11.2% between 2021 to 2028.

Some of the key factors driving the global Home infusion therapy Market growth are growing aging population and prevalence of chronic diseases such as cancer, obesity, diabetes, asthma, and other life-threatening conditions.

The global home infusion therapy market by North America and it held a maximum share of total revenue generated in 2020. This growth can be attributed to the presence of key players and good health awareness among people. The growth is also due to a large number of chronic diseases and growing geriatric population in this region.

Some of the major players of global Home infusion therapy market Baxter, B. Braun Melsungen AG, Care Fusion Corporation, ICU Medical, Inc., Fresenius Kabi AG, JMS Co. Ltd., Terumo Corporation, Smiths Medical and Caesarea Medical Electronics among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social